Inter System Biomedica Ethics Committee
About Inter System Biomedica Ethics Committee
Data last updated:
Inter System Biomedica Ethics Committee is a private not for profit company based in Mumbai, Maharashtra, India. It operates in the diagnostic and path labs segment of the healthcare sector. It was incorporated on 24 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85195MH2008NPL181521.
It is led by directors including Vanlila Nagindas Mehta and Deepak Tryambaklal Dave.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Regus Near Jw Mariott Juhu Tara Road, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.28 Lakh, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹67,146 (net margin 12.7%) and EBITDA of ₹79,782 (EBITDA margin 15.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inter System Biomedica Ethics Committee's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressRegus Near Jw Mariott Juhu Tara Road, Mumbai, Maharashtra, India – 400057
- IndustryHealthcare, Diagnostic & Path Labs, Other Human Health Activities, Human Health Activities
To see the full contact details of Inter System Biomedica Ethics Committee, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inter System Biomedica Ethics Committee is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Inter System Biomedica Ethics Committee, buy the company report.
Financials of Inter System Biomedica Ethics Committee
FY 2025 filings availableInter System Biomedica Ethics Committee reported revenue of ₹5.28 Lakh (up 87% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 87% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 230% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹79,782 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67,146 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 12.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inter System Biomedica Ethics Committee, buy the company report.
Board of directors of Inter System Biomedica Ethics Committee
Inter System Biomedica Ethics Committee has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vanlila Nagindas Mehta | Director | 24 Apr 2008 | 18 Years 6 Months | Current |
| Deepak Tryambaklal Dave | Director | 15 Jun 2009 | 17 Years 4 Months | Current |
| Jayashree Vinay Joshi | Director | 15 Jun 2009 | 17 Years 4 Months | Current |
| Meena Laxmishankar Dave | Director | 08 May 2023 | 3 Years 6 Months | Current |
Peer comparison
Inter System Biomedica Ethics Committee is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Suswastha Diagnostic Private Limited | ₹5.37 Lakh (FY 2025) | -23.0% | Kolkata, West Bengal, India | |||
| Medihopes Solution Private Limited | ₹5.37 Lakh (FY 2025) | 3776.0% | New Delhi, Delhi, India | |||
| South Asia Healthcare and Research Private Limited | ₹5.36 Lakh (FY 2025) | -91.0% | Kolkata, West Bengal, India | |||
| Miv Apnaopd Healthcare Services Private Limited | ₹5.31 Lakh (FY 2025) | 26172.0% | Jaipur, Rajasthan, India | |||
| Renuson Healthcare Private Limited | ₹5.3 Lakh (FY 2025) | -42.0% | Thane, Maharashtra, India | |||
| Inter System Biomedica Ethics Committeethis company | ₹5.28 Lakh (FY 2025) | ₹67,146 | 12.7% | 87.0% | Mumbai, Maharashtra, India | |
| Dr Rathores Homoeopathy Private Limited | ₹5.22 Lakh (FY 2025) | 12.0% | Lucknow, Uttar Pradesh, India | |||
| Himbharat Arogyam Private Limited | ₹5.21 Lakh (FY 2025) | Shimla, Himachal Pradesh, India | ||||
| Pharmasky Healthcare Private Limited | ₹5.21 Lakh (FY 2024) | Varanasi, Uttar Pradesh, India | ||||
| SN Eye Care Private Limited | ₹5.2 Lakh (FY 2025) | -58.0% | Navi Mumbai, Maharashtra, India | |||
| Generic Diagnostic Centre Private Limited | ₹5.2 Lakh (FY 2025) | 10.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Inter System Biomedica Ethics Committee, buy the company report.
Legal cases
No court or tribunal cases involving Inter System Biomedica Ethics Committee are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inter System Biomedica Ethics Committee; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Inter System Biomedica Ethics Committee; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Inter System Biomedica Ethics Committee has 11 board changes on record since 2008: 4 appointments and 7 cessations. The latest: Meena Laxmishankar Dave ceased to be Additional Director on 29 Sep 2023.
2 earlier events are in the company report.
Frequently asked questions
Inter System Biomedica Ethics Committee is an active private not for profit company based in Mumbai, Maharashtra, India. The company works in diagnostic and path labs, within the healthcare industry. It was incorporated on 24 April 2008 (18+ years old) and is registered under CIN U85195MH2008NPL181521.
Inter System Biomedica Ethics Committee has 4 current directors:
- Vanlila Nagindas Mehta - Director
- Deepak Tryambaklal Dave - Director
- Jayashree Vinay Joshi - Director
- Meena Laxmishankar Dave - Director
The latest financial statements of Inter System Biomedica Ethics Committee on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Inter System Biomedica Ethics Committee is U85195MH2008NPL181521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inter System Biomedica Ethics Committee was incorporated on 24 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Inter System Biomedica Ethics Committee by revenue are Suswastha Diagnostic Private Limited, Medihopes Solution Private Limited, South Asia Healthcare and Research Private Limited, Miv Apnaopd Healthcare Services Private Limited, Renuson Healthcare Private Limited and 5 more, all in the same principal business activity (human health activities).
Meena Laxmishankar Dave ceased to be Additional Director on 29 Sep 2023. Meena Laxmishankar Dave was appointed as Director on 08 May 2023. Balwant Digamber Samant ceased to be Director on 13 Jun 2019. Inter System Biomedica Ethics Committee has 11 board changes on record in total.
The registered office of Inter System Biomedica Ethics Committee is at Regus Near Jw Mariott Juhu Tara Road, Mumbai, Maharashtra, India – 400057.
Inter System Biomedica Ethics Committee operates in the healthcare industry, in the diagnostic and path labs segment.
The compliance status of Inter System Biomedica Ethics Committee is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.
Inter System Biomedica Ethics Committee can be reached at its registered office: Regus Near Jw Mariott Juhu Tara Road, Mumbai, Maharashtra, India – 400057.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
